Biovet JSC (LTS:0III) EBITDA Margin %: 9.55% (As of Dec. 2016)


What is Biovet JSC EBITDA Margin %?

Biovet JSC LTS:0III EBITDA Margin % is 9.55% as of Dec. 2016. The stock has 1 warning sign investors should review.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Biovet JSC's EBITDA for the three months ended in Dec. 2016 was лв6.50 Mil. Biovet JSC's Revenue for the three months ended in Dec. 2016 was лв68.11 Mil. Therefore, Biovet JSC's EBITDA margin for the quarter that ended in Dec. 2016 was 9.55%.

Biovet JSC  (LTS:0III) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Biovet JSC EBITDA Margin % Related Terms

Biovet JSC EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Biovet JSC's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biovet JSC EBITDA Margin % Chart

Biovet JSC Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
EBITDA Margin %
Get a 7-Day Free Trial 6.24 7.16 10.21 6.59 8.68

Biovet JSC Quarterly Data
Dec09 Dec10 Dec11 Dec12 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.67 4.96 15.57 3.76 9.55

LTS:0III vs ADMP, AGRX, BUDZ: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biovet JSC's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biovet JSC EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biovet JSC's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Biovet JSC's EBITDA Margin % falls into.


Biovet JSC EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Biovet JSC's EBITDA Margin % for the fiscal year that ended in Dec. 2016 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2016 )/Revenue (A: Dec. 2016 )
=19.74/227.358
=8.68 %

Biovet JSC's EBITDA Margin % for the quarter that ended in Dec. 2016 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2016 )/Revenue (Q: Dec. 2016 )
=6.504/68.111
=9.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 9.55% mean?
Biovet JSC (LTS:0III) has a EBITDA Margin % of 9.55% as of Dec. 2016. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Biovet JSC and its competitors.
Is Biovet JSC's EBITDA Margin % too high?
Biovet JSC's current EBITDA Margin % is 9.55%. The Drug Manufacturers industry median EBITDA Margin % is 12.44. Biovet JSC's value of 9.55% is 23.2% below this industry median.
How does Biovet JSC's EBITDA Margin % compare to ADMP and AGRX?
Biovet JSC's EBITDA Margin % of 9.55% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.44. Biovet JSC's value of 9.55% is 23.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biovet JSC's current EBITDA Margin % of 9.55% is 23.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Biovet JSC and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biovet JSC's current EBITDA Margin % is 9.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current EBITDA Margin % of 9.55%. The current EBITDA Margin % is 9.55% and 23.2% below the Drug Manufacturers industry median of 12.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current EBITDA Margin % is 9.55% as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biovet JSC Business Description

Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.